Antheia
Antheia is a pharmaceutical ingredient manufacturer using advanced biomanufacturing to transform essential medicine supply chains. The company's biomanufacturing platform enables efficient and on-demand production of key starting materials and active pharmaceutical ingredients, addressing drug shortages and improving global access to essential medicines.
Funding Round: Series C
Funding Amount: $56M
Date: 03-Jun-2025
Investors: Global Health Investment Corporation (GHIC), EDBI, ATHOS KG, Federov, Viking Global Investors, Sherpalo Ventures, S-Cubed Capital, In-Q-Tel (IQT), Civilization Ventures
Markets: Biotech, Pharma, Healthtech
HQ: Menlo Park, California, United States
Founded: 2015
Website: https://www.antheia.bio/
LinkedIn: https://www.linkedin.com/company/antheiabio
Twitter: https://twitter.com/antheiabio
Crunchbase: https://www.crunchbase.com/organization/antheia
Leave a Comment
Comments
No comments yet.